Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices 2575
Drug Controlled substance code Schedule
Meperidine intermediate-B ...... 9233 II Meperidine intermediate-C ...... 9234 II Metazocine ...... 9240 II Methadone ...... 9250 II Methadone intermediate ...... 9254 II Metopon ...... 9260 II Dextropropoxyphene, bulk (non-dosage forms) ...... 9273 II Morphine ...... 9300 II Oripavine ...... 9330 II Thebaine ...... 9333 II Dihydroetorphine ...... 9334 II Opium, raw ...... 9600 II Opium extracts ...... 9610 II Opium fluid extract ...... 9620 II Opium tincture ...... 9630 II Opium, powdered ...... 9639 II Opium, granulated ...... 9640 II Levo-alphacetylmethadol ...... 9648 II Opium poppy ...... 9650 II Oxymorphone ...... 9652 II Noroxymorphone ...... 9668 II Poppy Straw Concentrate ...... 9670 II Phenazocine ...... 9715 II Piminodine ...... 9730 II Racemethorphan ...... 9732 II Racemorphan ...... 9733 II Alfentanil ...... 9737 II Remifentanil ...... 9739 II Sufentanil ...... 9740 II Carfentanil ...... 9743 II Tapentadol ...... 9780 II Bezitramide ...... 9800 II Fentanyl ...... 9801 II Moramide-intermediate ...... 9802 II
The company plans to import small applicants therefore, may file written authority under the Controlled quantities of the listed controlled comments on or objections to the Substances Act to the Administrator of substances for the National Institute on issuance of the proposed registration on the Drug Enforcement Administration Drug Abuse (NIDA) for research or before March 11, 2019. Such persons (DEA), 28 CFR 0.100(b). Authority to activities. The company plans to import may also file a written request for a exercise all necessary functions with analytical reference standards for hearing on the application on or before respect to the promulgation and distribution to its customers for research March 11, 2019. implementation of 21 CFR part 1301, and analytical purposes. ADDRESSES: Written comments should incident to the registration of Dated: January 2, 2019. be sent to: Drug Enforcement manufacturers, distributors, dispensers, John J. Martin, Administration, Attention: DEA Federal importers, and exporters of controlled Assistant Administrator. Register Representative/DPW, 8701 substances (other than final orders in [FR Doc. 2019–01523 Filed 2–6–19; 8:45 am] Morrissette Drive, Springfield, Virginia connection with suspension, denial, or BILLING CODE 4410–09–P 22152. All requests for hearing must be revocation of registration) has been sent to: Drug Enforcement redelegated to the Assistant Administration, Attn: Administrator, Administrator of the DEA Diversion DEPARTMENT OF JUSTICE 8701 Morrissette Drive, Springfield, Control Division (‘‘Assistant Virginia 22152. All request for hearing Administrator’’) pursuant to section 7 of Drug Enforcement Administration should also be sent to: (1) Drug 28 CFR part 0, appendix to subpart R. [Docket No. DEA–392] Enforcement Administration, Attn: In accordance with 21 CFR Hearing Clerk/OALJ, 8701 Morrissette 1301.34(a), this is notice that on October Importer of Controlled Substances Drive, Springfield, Virginia 22152; and 23, 2018, Microgenics Corporation/ Application: Microgenics Corporation (2) Drug Enforcement Administration, Thermo Fisher Scientific located at Thermo Fisher Scientific Attn: DEA Federal Register 46500 Kato Rd., Fremont, California Representative/DPW, 8701 Morrissette ACTION: Notice of application. 94538, applied to be registered as an Drive, Springfield, Virginia 22152. importer of the below listed basic DATES: Registered bulk manufacturers of SUPPLEMENTARY INFORMATION: The classes of controlled substance listed in the affected basic classes, and Attorney General has delegated his schedules I and II.
Drug Controlled substance code Schedule
Cathinone ...... 1235 I
VerDate Sep<11>2014 18:55 Feb 06, 2019 Jkt 247001 PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 E:\FR\FM\07FEN1.SGM 07FEN1 2576 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Drug Controlled substance code Schedule
Mephedrone (4-Methyl-N-methylcathinone) ...... 1248 I Gamma Hydroxybutyric Acid ...... 2010 I Methaqualone ...... 2565 I Mecloqualone ...... 2572 I 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate ...... 7021 I AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ...... 7023 I AB–CHMINACA (N-(1-amino-3-methyl-1-≤oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ...... 7031 I MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ...... 7032 I 5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ...... 7033 I ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ...... 7035 I APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ...... 7048 I AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...... 7201 I Lysergic acid diethylamide ...... 7315 I Marihuana ...... 7360 I Tetrahydrocannabinols ...... 7370 I 3,4-Methylenedioxyamphetamine ...... 7400 I 3,4-Methylenedioxy-N-ethylamphetamine ...... 7404 I 3,4-Methylenedioxymethamphetamine ...... 7405 I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ...... 7518 I MDPV (3,4-Methylenedioxypyrovalerone) ...... 7535 I 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ...... 7538 I Butylone ...... 7541 I Pentylone ...... 7542 I alpha-pyrrolidinopentiophenone (a-PVP) ...... 7545 I Normorphine ...... 9313 I AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ...... 9551 I Acetylmethadol ...... 9601 I Alphamethadol ...... 9605 I Ketobemidone ...... 9628 I Noracymethadol ...... 9633 I Para-Fluorofentanyl ...... 9812 I 3-Methylfentanyl ...... 9813 I Alpha-methylfentanyl ...... 9814 I Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...... 9821 I 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ...... 9825 I 3-Methylthiofentanyl ...... 9833 I Cyclopropyl Fentanyl ...... 9845 I Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ...... 9850 I Amphetamine ...... 1100 II Methamphetamine ...... 1105 II Methylphenidate ...... 1724 II Amobarbital ...... 2125 II Pentobarbital ...... 2270 II Secobarbital ...... 2315 II Phencyclidine ...... 7471 II Cocaine ...... 9041 II Codeine ...... 9050 II Dihydrocodeine ...... 9120 II Oxycodone ...... 9143 II Hydromorphone ...... 9150 II Ecgonine ...... 9180 II Hydrocodone ...... 9193 II Levorphanol ...... 9220 II Meperidine ...... 9230 II Meperidine intermediate-B ...... 9233 II Methadone ...... 9250 II Dextropropoxyphene, bulk (non-dosage forms) ...... 9273 II Morphine ...... 9300 II Thebaine ...... 9333 II Levo-alphacetylmethadol ...... 9648 II Oxymorphone ...... 9652 II Carfentanil ...... 9743 II Tapentadol ...... 9780 II Fentanyl ...... 9801 II
The company plans to import the raw materials for InVitro Diagnostic Dated: December 21, 2018. listed controlled substances for quantitative assay. John J. Martin, feasibility studies for new products and Assistant Administrator. cross reactivity studies for existing [FR Doc. 2019–01513 Filed 2–6–19; 8:45 am] products. The products will serve as BILLING CODE 4410–09–P
VerDate Sep<11>2014 17:23 Feb 06, 2019 Jkt 247001 PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 E:\FR\FM\07FEN1.SGM 07FEN1